HYDREA

This brand name is authorized in United States. It is also authorized in Australia, Brazil, Canada, Estonia, Finland, France, Ireland, Japan, Lithuania, Mexico, Netherlands, New Zealand, Romania, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug HYDREA contains one active pharmaceutical ingredient (API):

1	Hydroxycarbamide UNII X6Q56QN5QC - HYDROXYUREA
	One of the mechanisms by which hydroxycarbamide acts is the elevation of foetal haemoglobin (HbF) concentrations in sickle cell patients. In addition hydroxycarbamide causes an immediate inhibition of DNA synthesis by acting as a ribonucleotide reductase inhibitor, without interfering with the synthesis of ribonucleic acid or protein.
	Read more about Hydroxycarbamide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
HYDREA Capsule	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L01XX05	Hydroxycarbamide	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XX Other antineoplastic agents
Discover more medicines within L01XX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	3093T
BR	Câmara de Regulação do Mercado de Medicamentos	505102501117316
CA	Health Products and Food Branch	00465283
EE	Ravimiamet	1036022, 1615698, 1878251
ES	Centro de información online de medicamentos de la AEMPS	61633
FI	Lääkealan turvallisuus- ja kehittämiskeskus	521757
FR	Base de données publique des médicaments	69700567
GB	Medicines & Healthcare Products Regulatory Agency	23907
IE	Health Products Regulatory Authority	61832
JP	医薬品医療機器総合機構	4229001M1027
LT	Valstybinė vaistų kontrolės tarnyba	1002639, 1066848, 1082392
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	508M2015
NL	Z-Index G-Standaard, PRK	2690
NZ	Medicines and Medical Devices Safety Authority	643
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W03542001
TN	Direction de la Pharmacie et du Médicament	5253081
TR	İlaç ve Tıbbi Cihaz Kurumu	8699525156679
US	FDA, National Drug Code	0003-0830